Clinical Trial Results:
A Randomized, Parallel Group, Double-Blind, Placebo Controlled Study to Evaluate the
Clinical Efficacy and Safety of BMS-582949 Given Orally to Subjects with Rheumatoid
Arthritis Having an Inadequate Response to Methotrexate.
Pharmacogenetics Blood Sample Amendment 01 (version 1.0, dated 19-Dec-2007);
Revised Protocol 01, incorporating administrative letter 01 and amendment 03 (version 1.0, dated 12-Mar-2008)
Summary
|
|
EudraCT number |
2008-000170-20 |
Trial protocol |
FR CZ ES |
Global completion date |
30 Sep 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
07 Dec 2016
|
First version publication date |
07 Dec 2016
|
Other versions |
|
Summary report(s) |
IM119-015_Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.